Activation of the mitogen-activated protein kinase signaling pathway is instrumental in determining the ability of Mycobacterium avium to grow in murine macrophages

Journal of Immunology

Volumn 168, Issue 2, 2002, Pages 825-833

  Tse, H M ^a   Josephy, S I ^a   Chan, E D ^a   Fouts, D ^a   Cooper, A M ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOOXYGENASE 2; CYTOKINE; INDOMETACIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CONTROLLED STUDY; DISEASE MODEL; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME INHIBITION; FEMALE; IN VITRO STUDY; MACROPHAGE; MOUSE; MYCOBACTERIUM AVIUM; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SIGNAL TRANSDUCTION;

EID: 0037080363     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.2.825     Document Type: Article

References (50)

1. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immune deficiency syndrome (AIDS)
2. Mycobacterium avium complex infection
3. Mycobacterium avium infection and AIDS: A therapeutic dilemma in rapid evolution
4. The Mycobacterium avium complex
5. Differential colonial characteristics of mycobacteria on Middlebrook and Cohn 7H10 agar-base medium
6. A mutant of a scotochromogenic Mycobacterium detected by colony morphology and lipid studies
7. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice
8. Characterization and growth in human macrophages of Mycobacterium avium complex strains isolated from the blood of patients with acquired immune deficiency
9. Treatment of Mycobacterium a vium complex infection: Do the results of the in vitro susceptibility tests predict therapeutic outcome in humans?
10. Peptidoglycolipid nature of the superficial cell wall sheath of smooth-colony-forming mycobacteria
11. Chemical basis of rough and smooth variation in mycobacteria
12. Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens
13. Search for the molecular basis of morphological variation in Mycobacterium avium
14. Characterization of the virulence of Mycobacterium avium complex (MAC) isolates in mice
15. Role of γ interferon and tumor necrosis factor α during T-cell-independent and -dependent phases of Mycobacterium avium infection
16. Tumour necrosis factor-α (TNF-α) in the host resistance to mycobacteria of distinct virulence
17. Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor
18. Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor α production in infected mice and in in vitro-cultured mouse macrophages
19. Colonial morphotype as a determinant of cytokine expression by monocytes infected with Mycobacterium avium
20. Induction of IL-1b, IL-6, TNF-α, GM-CSF, and G-CSF in human macrophages by smooth transparent and smooth opaque colonial variants of Mycobacterium avium
21. Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells
22. 2-terminal kinase: Correlation with its inhibitory effect on tumor necrosis factor-α production
23. YopJ of Yersinia pseudotuberculosis is required for the inhibition of macrophage TNF-α production and downregulation of the MAP kinases p38 and JNK
24. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells
25. Listeriolysin O activates mitogen-activated protein kinase in eucaryotic cells
26. Listeria monocytogenes invasion of epithelial cells requires the MEK-1/ERK-2 mitogen-activated protein kinase pathway
27. Molecular basis of colony morphology in Mycobacterium avium
28. Similar responses by macrophages from young and old mice infected with Mycobacterium tuberculosis
29. Susceptibility of a panel of virulent strains of Mycobacterium tuberculosis to reactive nitrogen intermediates
30. MAP kinase activation in macrophages
31. MAPK in Fcγ receptor-stimulated TNF-α synthesis
32. Evolution of an immune suppressive macrophage phenotype as a product of p38 MAPK activation in polymicrobial sepsis
33. Exaggerated human monocyte IL-10 concomitant to minimal TNF-α induction by heat-shock protein 27 (Hsp27) suggests Hsp27 is primarily an anti-inflammatory stimulus
34. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade
35. Activation of arachidonate release and cytosolic phospholipase A2 via extracellular signal-regulated kinase and p38 mitogen-activated protein kinase in macrophages stimulated by bacteria or zymosan
36. The pyridinyl imidazole inhibitor SB203580 blocks phosphoinositide-dependent protein kinase activity, protein kinase B phosphorylation, and retinoblastoma hyperphosphorylation in interleukin-2-stimulated T cells independently of p38 mitogen-activated protein kinase
37. Indomethacin-sensitive monocyte killing defect in a child with disseminated atypical mycobacterial disease
38. Envelope glycoprotein (gp120) from HIV-1 enhances Mycobacterium avium growth in human bronchoalveolar macrophages: An effect mediated by enhanced prostaglandin synthesis
39. Inhibition of prostaglandin endoperoxidase synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase
40. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
41. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059: SB 203580 also inhibits thromboxane synthase
42. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors
43. Macrophage apoptosis in mycobacterial infection
44. Apoptosis of Mycobacterium avium-infected macrophages is mediated by both tumour necrosis factor (TNF) and Fas, and involves the activation of caspases
45. Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4
46. Phosphorylation and regulation of Raf by Akt (protein kinase B)
47. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt
48. Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macropbage IL-12 production by targeting ERK MAP kinase
49. MAPK cascade
50. MAPK in a mouse macrophage cell line